Fig. 3

Tile panel demonstrating molecular characteristics by next-generation sequence analysis of patients with histone H3 K27-mutant diffuse non-midline glioma (n = 16) and H3 G34-mutant diffuse hemispheric glioma (n = 9) in the Kansai Network